Corporate Banner
Satellite Banner
Scientific Community
Join | Sign in

  News Archive

Delenex Announces New Clinical Data
Thursday, April 16, 2015
New clinical data show biological activity of DLX105 in patients with Behçet’s disease.

NMR ‘Fingerprinting’ for Monoclonal Antibodies
Thursday, April 16, 2015
Study by NIST researchers shows the use of NMR spectroscopy for measuring the structural congfiguration of monoclonal antibodies.

Compugen Obtains Rights to Use Biological Systems and Materials
Wednesday, April 15, 2015
Additional capabilities anticipated to enhance research and development of Compugen’s immuno-oncology programs.

Promising Developments In Tackling Resistance To Blood Cancer Drugs
Wednesday, April 15, 2015
A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton.

Recruiting The Entire Immune System To Attack Cancer
Wednesday, April 15, 2015
Stimulating both major branches of the immune system halts tumor growth more effectively.

MorphoSys to Receive Milestone Payment for Guselkumab Program
Tuesday, April 14, 2015
Company initiates phase 2 clinical trial in psoriatic arthritis with the HuCAL antibody.

ThromboGenics and VIB Launch New Oncology Company
Tuesday, April 14, 2015
Oncurious NV to develop TB-403 for pediatric brain tumors.

New Antibody Therapy Shows Promise in Suppressing HIV Infection
Tuesday, April 14, 2015
New study finds that administration of 3BNC117 can catch HIV off guard and reduce viral loads.

Personalized Melanoma Vaccines Marshal Powerful Immune Response
Wednesday, April 08, 2015
Vaccines target unique mutations in each patient’s tumor.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1423

SELECTBIO Market Reports
Go to LabTube
Go to eposters